Denali Therapeutics

161 Oyster Point Blvd- South, San Francisco, CA, 94080, United States

Company Overview

Company Name

Denali Therapeutics

Address

161 Oyster Point Blvd- South, San Francisco, CA, 94080, United States

Website

dnli.com

About Denali Therapeutics

Denali Therapeutics is a biopharmaceutical company based in San Francisco, California, focused on developing treatments for neurodegenerative and lysosomal storage diseases. The company leverages recent scientific advancements to discover and develop effective molecular therapeutics targeting genetic causes and biological processes underlying these debilitating conditions.

Frequently Asked Questions about Denali Therapeutics

Technologies Used

Key Decision Makers

Malia Koons Sr. Clinical Trial Manager
LinkedIn